July 2024
1. MINAMI Y, Iwaya T
   Are Sodium-Glucose Cotransporter-2 Inhibitors Fantastic for Coronary Plaque Stabilization?
   Am J Cardiol. 2024;222:95.
   

   >> Share

   
   June 2024
2. ASBEUTAH AA, Daher R, Malik A, Hariri E, et al
   The Effect of Eicosapentaenoic and Docosahexaenoic Acid Supplementation on Coronary Artery Calcium Progression in Subjects with Diabetes and Coronary Artery Disease: A Secondary Analysis of a Randomized Trial.
   Am J Cardiol. 2024 Jun 15:S0002-9149(24)00422.
   

   >> Share

   
   
3. DAVIS MG, Blankenship JC
   Quality of Life in Elderly Diabetic Coronary Patients.
   Am J Cardiol. 2024 Jun 14:S0002-9149(24)00438.
   

   >> Share

   
   May 2024
4. PARK DY, Jamil Y, Moumneh MB, Batchelor W, et al
   Quality of Life in Older Adults with Stable Ischemic Heart Disease and Diabetes Mellitus: A Post-hoc Analysis of the BARI 2D Trial.
   Am J Cardiol. 2024 May 24:S0002-9149(24)00370.
   

   >> Share

   
   
5. CASTIELLO DS, Piccolo R, Esposito G
   Is diabetes still a risk factor for PCI-related outcomes in the era of imaging-guided PCI?
   Am J Cardiol. 2024 May 22:S0002-9149(24)00392.
   

   >> Share

   
   
6. YAMAMOTO K, Shiomi H, Morimoto T, Miyazawa A, et al
   Optimal Intravascular Ultrasound-Guided Percutaneous Coronary Intervention in Patients With Multivessel Disease and Diabetes.
   Am J Cardiol. 2024 May 11:S0002-9149(24)00335.
   

   >> Share

   
   
7. MAN LAM SH, Alam U, Lip GYH
   Cardiovascular and renal benefit of sodium-glucose co-transporter type 2 inhibitors in patients with Type 2 Diabetes.
   Am J Cardiol. 2024 May 9:S0002-9149(24)00340.
   

   >> Share

   
   April 2024
8. CORDERO A, Sirera D, Mendez-Gallego J, Echeverria I, et al
   Effect of diabetes mellitus on global longitudinal strain.
   Am J Cardiol. 2024 Apr 26:S0002-9149(24)00281.
   

   >> Share

   
   
9. MOIZ A, Levett JY, Filion KB, Peri K, et al
   Long-Term Efficacy and Safety of Once-Weekly Semaglutide for Weight Loss in Patients Without Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
   Am J Cardiol. 2024 Apr 26:S0002-9149(24)00319.
   

   >> Share

   
   
10. EDMONSTON D, Mulder H, Lydon E, Chiswell K, et al
    Kidney and Cardiovascular Effectiveness of Empagliflozin Compared to Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes.
    Am J Cardiol. 2024 Apr 17:S0002-9149(24)00268.
    

    >> Share

    
    March 2024
11. YOU Y, Zeng N, Wu W, Liu B, et al
    Association of Serum Homocysteine with Peripheral Arterial Disease in Non-Diabetic Patients: A Study Based on National Health and Nutrition Examination Survey Database.
    Am J Cardiol. 2024 Mar 6:S0002-9149(24)00169.
    

    >> Share

    
    
12. SINGH S, Garg A, Tantry US, Bliden K, et al
    Cardiovascular Outcomes With Empagliflozin and Dapagliflozin in Patients Without Diabetes.
    Am J Cardiol. 2024 Mar 1:S0002-9149(24)00161.
    

    >> Share

    
    February 2024
13. AGARWAL S, Qamar U, Fujiwara Y, Guha A, et al
    The Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Cardiovascular Outcomes in Patients with Cancer: A Systematic Review and Meta-Analysis.
    Am J Cardiol. 2024 Feb 17:S0002-9149(24)00101.
    

    >> Share

    
    
14. PERERA S, Zheng Z, Wadhera R
    Cardiovascular Health, Lifestyle Factors, and Social Determinants Among Asian Sub-Populations in the US.
    Am J Cardiol. 2024 Feb 16:S0002-9149(24)00098.
    

    >> Share

    
    January 2024
15. GRONLUND T, Kaikkonen K, Junttila MJ, Kiviniemi AM, et al
    Lifestyle and Cardiac Structure and Function in Healthy Midlife Population.
    Am J Cardiol. 2024;211:291-298.
    

    >> Share

    
    
16. KUROZUMI A, Shishido K, Yamashita T, Sato D, et al
    Sodium-glucose Cotransporter-2 Inhibitors Stabilize Coronary Plaques in Acute Coronary Syndrome with Diabetes Mellitus.
    Am J Cardiol. 2024 Jan 10:S0002-9149(24)00025.
    

    >> Share

    
    
17. HU M, Yang T, Yang Y
    Causal Associations of Education Level With Cardiovascular Diseases, Cardiovascular Biomarkers, and Socioeconomic Factors.
    Am J Cardiol. 2024;213:76-85.
    

    >> Share

    
    
18. GOKHALE KM, Chandan JS, Sainsbury C, Tino P, et al
    Using Repeated Measurements to Predict Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus.
    Am J Cardiol. 2024;210:133-142.
    

    >> Share

    
    December 2023
19. JAMIL Y, Park DY, Verde LM, Sherwood MW, et al
    Do Clinical Outcomes and Quality of Life Differ by the Number of Antianginals for Stable Ischemic Heart Disease? Insights from the BARI2D Trial.
    Am J Cardiol. 2023 Dec 29:S0002-9149(23)01437.
    

    >> Share

    
    
20. CARBONE S, Abbate A
    SGLT2 inhibitors in Patients Admitted for Acute Heart Failure: The Earlier the Better.
    Am J Cardiol. 2023 Dec 15:S0002-9149(23)01398.
    

    >> Share

    
    November 2023
21. YAN CL, Erben A, Sancassani R
    Evaluation of Inpatient Sodium-Glucose Co-Transporter-2 Inhibitor Use in Patients Hospitalized for Acute Heart Failure.
    Am J Cardiol. 2023 Nov 7:S0002-9149(23)01293.
    

    >> Share

    
    October 2023
22. ZGHEBI SS, Kontopantelis E, Mamas MA
    Cardiovascular risk prediction tools in people with diabetes - Aren't there enough? What is still missing?
    Am J Cardiol. 2023 Oct 25:S0002-9149(23)01210.
    

    >> Share

    
    
23. VERA A, Cecconi A, Ximenez-Carrillo A, Ramos C, et al
    Left Atrial Strain Predicts Stroke Recurrence and Death in Patients With Cryptogenic Stroke.
    Am J Cardiol. 2023;210:51-57.
    

    >> Share

    
    
24. ZELKO A, Salerno PRVO, Al-Kindi S, Ho F, et al
    Geographically Weighted Modeling to Explore Social and Environmental Factors Affecting County-Level Cardiovascular Mortality in People With Diabetes in the United States: A Cross-Sectional Analysis.
    Am J Cardiol. 2023 Oct 18:S0002-9149(23)01085.
    

    >> Share

    
    
25. DATTA BK, Coughlin SS, Gummadi A, Mehrabian D, et al
    Perceived Social Support and Cardiovascular Risk Among Nonelderly Adults in the United States.
    Am J Cardiol. 2023 Oct 18:S0002-9149(23)01114.
    

    >> Share

    
    
26. DESAI U, Babcock A, Wang Y, Akbarnejad H, et al
    Real-World Incidence of Adverse Clinical Outcomes Among People With Coronary Artery Disease and/or Peripheral Artery Disease in Relation to Vascular Risk in the United States.
    Am J Cardiol. 2023;208:44-52.
    

    >> Share

    
    September 2023
27. SEEGERS LM, Yeh DD, Wood MJ, Yonetsu T, et al
    Cardiovascular Risk Factors and Culprit Plaque Characteristics in Women With Acute Coronary Syndromes.
    Am J Cardiol. 2023;207:13-20.
    

    >> Share

    
    
28. ASHIQ S, Sabar MF, Hyder SN
    Genetic Risk Score Constructed from Polymorphisms in the VEGFA, TBX5, and SMAD7 Genes Provides Novel Insights into the Molecular Mechanisms of the Tetralogy of Fallot and Ventricular Septal Defect (Case-Control Study from the Pakistani Population).
    Am J Cardiol. 2023;203:368-375.
    

    >> Share

    
    
29. VERDOIA M, Zilio F, Gioscia R, Viola O, et al
    Prognostic Impact of Drug-Coated Balloons in Patients With Diabetes Mellitus: A Propensity-Matched Study.
    Am J Cardiol. 2023;206:73-78.
    

    >> Share

    
    
30. SANTANA JC, Dangl M, Albosta M, Colombo R, et al
    Outcomes of Acute Myocardial Infarction in Female Patients With Type 1 Diabetes Mellitus.
    Am J Cardiol. 2023;206:12-13.
    

    >> Share

    
    August 2023
31. CIOFANI JL, Han D, Allahwala UK, Woolf B, et al
    Lipids, Blood Pressure, and Diabetes Mellitus on Risk of Cardiovascular Diseases in East Asians: A Mendelian Randomization Study.
    Am J Cardiol. 2023;205:329-337.
    

    >> Share

    
    
32. KAWADA T
    Statin Use and Risk of Clinical Outcomes With Special Reference to Kidney Disease and Concurrent Medications in Patients With Diabetes Mellitus.
    Am J Cardiol. 2023 Aug 22:S0002-9149(23)00777.
    

    >> Share

    
    
33. AIZAWA Y
    Sodium-Glucose Cotransporter-2 Inhibitors and Lower-Extremity Amputation.
    Am J Cardiol. 2023;201:388-389.
    

    >> Share

    
    
34. EKMEJIAN A, Brieger D, Bhat A, Sritharan H, et al
    Vessel-Specific Outcomes of Deferred Revascularization Following Negative Fractional Flow Reserve.
    Am J Cardiol. 2023;201:320-327.
    

    >> Share

    
    
35. PATIL T, Cook M, Hobson J, Kaur A, et al
    Evaluating the Safety of Sodium-Glucose Cotransporter-2 Inhibitors in a Nationwide Veterans Health Administration Observational Cohort Study.
    Am J Cardiol. 2023;201:281-293.
    

    >> Share

    
    
36. MURPHY D, Firoozi S, Herzog CA, Banerjee D, et al
    Cardiac Troponin, Kidney Function, Heart Failure and Mortality After Myocardial Infarction in Patients With and Without Kidney Impairment.
    Am J Cardiol. 2023;204:383-391.
    

    >> Share

    
    July 2023
37. PARK HW, Jo S, Park KS, Lee H, et al
    Differential Impact of Degree of Hypertension on Subclinical Coronary Atherosclerosis in Asymptomatic Subjects With and Without Diabetes Mellitus.
    Am J Cardiol. 2023;203:343-351.
    

    >> Share

    
    
38. AFIFY H, Gonzalez-Morales U, Asmar A, Alvarez CA, et al
    Association of Thiazide Diuretics With Diabetes Progression, Kidney Disease Progression, Cardiovascular Outcomes, and Death Among Patients With Diabetes Who Initiate Statins.
    Am J Cardiol. 2023;203:274-284.
    

    >> Share

    
    
39. CHARITHA KONERU S, Sikand G, Agarwala A
    Optimizing Dietary Patterns and Lifestyle to Reduce Atherosclerotic Cardiovascular Risk Among South Asian Individuals.
    Am J Cardiol. 2023;203:113-121.
    

    >> Share

    
    
40. HAMED M, Morcos R, Elbadawi A, Osman A, et al
    Percutaneous Left Atrial Appendage Closure Among Patients With Diabetes (Insights from a National Database).
    Am J Cardiol. 2023;202:144-150.
    

    >> Share

    
    
41. NARDI-AGMON I, Cohen G, Itzhaki Ben Zadok O, Steinberg DM, et al
    Cancer Incidence and Survival Among Patients Following an Acute Coronary Syndrome.
    Am J Cardiol. 2023;202:50-57.
    

    >> Share

    
    
42. ZAHID S, Khan SU
    Time-Varying Cardiovascular Effects of Sodium-Glucose Cotransporter Inhibitors in Patients With Heart Failure With Preserved Ejection Fraction.
    Am J Cardiol. 2023 Jul 6:S0002-9149(23)00451.
    

    >> Share

    
    June 2023
43. OBISESAN OH, Orimoloye OA, Wang FM, Dardari ZA, et al
    Coronary Artery Calcium Scores in Older Adults With Diabetes and Their Association With Diabetes-Specific Risk Enhancers (from the Atherosclerosis Risk in Communities Study).
    Am J Cardiol. 2023;201:219-223.
    

    >> Share

    
    
44. LAUKKANEN JA, Kurl S, Kunutsor SK
    Cardiorespiratory Fitness and Risk of Aortic Stenosis (from a Prospective Cohort Analysis).
    Am J Cardiol. 2023;201:101-106.
    

    >> Share

    
    
45. NARGESI AA, Clark C, Aminorroaya A, Chen L, et al
    Persistence on Novel Cardioprotective Antihyperglycemic Therapies in the United States.
    Am J Cardiol. 2023;196:89-98.
    

    >> Share

    
    May 2023
46. NICHOLS GA, Qiao Q, Linden S, Kraus BJ, et al
    Medical Costs of Chronic Kidney Disease and Type 2 Diabetes Among Newly Diagnosed Heart Failure Patients With Reduced, Mildly Reduced, and Preserved Ejection Fraction.
    Am J Cardiol. 2023;198:72-78.
    

    >> Share

    
    
47. ZAATARI G, Bello D, Blandon C, Abbott JD, et al
    Impact of Diabetes Mellitus on Benefit of beta-Blocker Therapy After Myocardial Infarction.
    Am J Cardiol. 2023 May 12:S0002-9149(23)00232.
    

    >> Share

    
    April 2023
48. KLEIN LW
    Determinants of Long-Term Adherence to Cardioprotective Diabetes Medications.
    Am J Cardiol. 2023 Apr 12:S0002-9149(23)00159.
    

    >> Share

    
    January 2023
49. ARMAN HE, Ali SA, Zenisek J, Patidar KR, et al
    Assessment of Vascular and Valvular Calcification Improves Screening for Coronary Artery Disease Before Liver Transplantation.
    Am J Cardiol. 2023;191:23-31.
    

    >> Share

    
    
50. GRUNDY SM, Vega GL, Wong ND
    Is There a Role for Coronary Calcium in Patients With Diabetes?
    Am J Cardiol. 2023;190:98-101.
    

    >> Share

    
    December 2022
51. COONS JC, Kliner J, Mathier MA, Mulukutla S, et al
    Impact of a Medication Optimization Clinic on Heart Failure Hospitalizations.
    Am J Cardiol. 2022;188:102-109.
    

    >> Share

    
    
52. SUBRAMANIAN M, Sravani V, Krishna SP, Bijjam S, et al
    Efficacy of SGLT2 Inhibitors in Patients With Diabetes and Nonobstructive Hypertrophic Cardiomyopathy.
    Am J Cardiol. 2022;188:80-86.
    

    >> Share

    
    
53. PEERWANI G, Khan SM, Khan MD, Bashir F, et al
    Gender Differences in Clinical Outcomes After Percutaneous Coronary Intervention-Analysis of 15,106 Patients from the Cardiac Registry of Pakistan Database.
    Am J Cardiol. 2022;188:61-67.
    

    >> Share

    
    November 2022
54. GAY HC, Yu J, Persell SD, Linder JA, et al
    Comparison of Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Prescribing in Patients With Diabetes Mellitus With and Without Cardiovascular Disease.
    Am J Cardiol. 2022 Nov 21:S0002-9149(22)01131.
    

    >> Share

    
    
55. KHAYATA M, Hackney N, Addoumieh A, Aklkharabsheh S, et al
    Impact of Opioid Epidemic on Infective Endocarditis Outcomes in the United States: From the National Readmission Database.
    Am J Cardiol. 2022;183:137-142.
    

    >> Share

    
    
56. AHMED A, Imran L, Naeem U, Jawed A, et al
    Meta-Analysis on the Efficacy of Novel Glucose-Lowering Agents in Older Patients With Type 2 Diabetes Mellitus.
    Am J Cardiol. 2022;187:127-130.
    

    >> Share

    
    
57. HASAN MT, Awad AK, Shih M, Attia AN, et al
    Meta-Analysis on the Safety and Efficacy of Sodium Glucose Cotransporters 2 Inhibitors in Patients With Heart Failure With and Without Diabetes.
    Am J Cardiol. 2022;187:93-99.
    

    >> Share

    
    
58. KLEIN LW
    Why Are Cardiologists Not Prescribing the New Diabetes Medications?
    Am J Cardiol. 2022;187:74-75.
    

    >> Share

    
    October 2022
59. OKOROIKE H, Patel S, Simone P, Lavelle R, et al
    Impact of Inpatient Initiation of Sodium-Glucose Cotransporter-2 Inhibitors on Prescription Rates in Patients With Heart Failure With Reduced Ejection Fraction.
    Am J Cardiol. 2022 Oct 22. pii: S0002-9149(22)01042.
    

    >> Share

    
    September 2022
60. AL RIFAI M, Szklo M, Patel J, Blaha MJ, et al
    Statin Use and Risk of Diabetes by Subclinical Atherosclerosis Burden (from a Multi-Ethnic Study of Atherosclerosis Report).
    Am J Cardiol. 2022 Sep 30. pii: S0002-9149(22)00958.
    

    >> Share

    
    
61. AVILA-VANZZINI N, Medina-Paz L, Berrios-Barcenas E, Arias-Godinez A, et al
    Anatomical and Clinical Factors Associated With Valvulopathy and Aortopathy in Mexican Patients With Bicuspid Aortic Valves.
    Am J Cardiol. 2022 Sep 23. pii: S0002-9149(22)00952.
    

    >> Share

    
    August 2022
62. GIMNICH OA, Ortiz CB, Yang EY, Chen C, et al
    Comparison of Longitudinal Skeletal Thigh Muscle Findings With Magnetic Resonance Imaging in Patients With Peripheral Artery Disease With-Versus-Without Diabetes Mellitus.
    Am J Cardiol. 2022 Aug 20. pii: S0002-9149(22)00757.
    

    >> Share

    
    
63. PATOULIAS D, Papadopoulos C, Fragakis N, Doumas M, et al
    Updated Meta-Analysis Assessing the Cardiovascular Efficacy of Tirzepatide.
    Am J Cardiol. 2022 Aug 14. pii: S0002-9149(22)00734.
    

    >> Share

    
    
64. GORGIS S, Ehrman JK, Blaha MJ, Qureshi WT, et al
    Relation of Exercise Capacity to Incident Heart Failure Among Men and Women With Coronary Heart Disease (from the Henry Ford Exercise Testing [FIT] Project).
    Am J Cardiol. 2022 Aug 12. pii: S0002-9149(22)00746.
    

    >> Share

    
    
65. LOPEZ PD, Bhatia K, Bohra C, Mahmood K, et al
    Benefits of Adding Glucagon-Like Peptide 1 Receptor Agonists to Sodium-Glucose Co-Transporter 2 Inhibitors in Diabetic Patients With Atherosclerotic Disease and Heart Failure.
    Am J Cardiol. 2022 Aug 11. pii: S0002-9149(22)00750.
    

    >> Share

    
    July 2022
66. PATOULIAS D, Papadopoulos C, Fragakis N, Karagiannis A, et al
    Meta-Analysis Evaluating the Cardiovascular Efficacy of Sodium-Glucose Co-Transporter-2 Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction According to Baseline Anemia.
    Am J Cardiol. 2022 Jul 21. pii: S0002-9149(22)00661.
    

    >> Share

    
    
67. PATOULIAS D, Dimosiari A, Michailidis T, Roditis P, et al
    Meta-analysis Evaluating the Effect of Sodium-Glucose Co-Transporter-2 Inhibitors on the Risk for New-Onset Obstructive Sleep Apnea in Patients With Type 2 Diabetes Mellitus Regardless of Cardiovascular Disease at Baseline.
    Am J Cardiol. 2022 Jul 19. pii: S0002-9149(22)00660.
    

    >> Share

    
    
68. ATTAR R, Wu A, Wojdyla D, Jensen SE, et al
    Outcomes After Acute Coronary Syndrome in Patients With Diabetes Mellitus and Peripheral Artery Disease (from the TRACER, TRILOGY-ACS, APPRAISE-2, and PLATO Clinical Trials).
    Am J Cardiol. 2022 Jul 11. pii: S0002-9149(22)00579.
    

    >> Share

    
    
69. CHAAR D, Dumont BL, Vulesevic B, Neagoe PE, et al
    Neutrophils and Circulating Inflammatory Biomarkers in Diabetes Mellitus and Heart Failure With Preserved Ejection Fraction.
    Am J Cardiol. 2022 Jul 7. pii: S0002-9149(22)00586.
    

    >> Share

    
    
70. KWON CH, Kim YJ, Kim MJ, Cha MJ, et al
    Effect of Sodium-Glucose Cotransporter Inhibitors on Major Adverse Cardiovascular Events and Hospitalization for Heart Failure in Patients With Type 2 Diabetes Mellitus and Atrial Fibrillation.
    Am J Cardiol. 2022 Jul 7. pii: S0002-9149(22)00583.
    

    >> Share

    
    
71. KATOH H, Ohya M, Kadota K
    Impact of Periprocedural Myocardial Infarction on 10-Year Mortality After Coronary Stent Implantation in Patients With Diabetes Mellitus.
    Am J Cardiol. 2022 Jul 3. pii: S0002-9149(22)00578.
    

    >> Share

    
    June 2022
72. PATOULIAS D, Dimosiari A
    Meta-analysis Addressing the Cardiovascular Safety of Bexagliflozin in Patients With Type 2 Diabetes Mellitus.
    Am J Cardiol. 2022 Jun 27. pii: S0002-9149(22)00542.
    

    >> Share

    
    
73. COUGHLIN SS, Datta B, Guha A, Wang X, et al
    Cardiovascular Health Among Cancer Survivors. From the 2019 Behavioral Risk Factor Surveillance System Survey.
    Am J Cardiol. 2022 Jun 27. pii: S0002-9149(22)00596.
    

    >> Share

    
    
74. PATOULIAS D, Doumas M, Papadopoulos C
    Meta-Analysis Evaluating the Effect of Sodium-Glucose Co-Transporter-2 Inhibitors on Pulmonary Artery Pressure Indices.
    Am J Cardiol. 2022;172:169-170.
    

    >> Share

    
    May 2022
75. GUPTA K, Obeidat L, Kakar TS, Fadel RA, et al
    Trends in Undiagnosed Diabetes Mellitus Among United States Adults: Cross-Sectional Analyses from NHANES 2011-2020.
    Am J Cardiol. 2022 May 22. pii: S0002-9149(22)00446.
    

    >> Share

    
    
76. PATOULIAS D, Papadopoulos C, Kassimis G, Fragakis N, et al
    Meta-Analysis Assessing the Cardiovascular Safety of Semaglutide for the Treatment of Overweight or Obesity.
    Am J Cardiol. 2022 May 19. pii: S0002-9149(22)00444.
    

    >> Share

    
    
77. CHOI SH, Yoon GS, Lee MJ, Park SD, et al
    Prognostic Impact of Plasma Glucose on Patients With Cardiogenic Shock With or Without Diabetes Mellitus from the SMART RESCUE Trial.
    Am J Cardiol. 2022 May 9. pii: S0002-9149(22)00415.
    

    >> Share

    
    
78. ISTANBULY S, Matetic A, Roberts DJ, Myint PK, et al
    Relation of Extracardiac Vascular Disease and Outcomes in Patients With Diabetes (1.1 Million) Hospitalized for Acute Myocardial Infarction.
    Am J Cardiol. 2022 May 9. pii: S0002-9149(22)00398.
    

    >> Share

    
    
79. PATOULIAS D, Papadopoulos C, Fragakis N, Karagiannis A, et al
    Meta-Analysis Assessing the Cardiovascular Efficacy of Sodium-Glucose Co-Transporter-2 Inhibitors in Patients With Chronic Obstructive Pulmonary Disease.
    Am J Cardiol. 2022 May 9. pii: S0002-9149(22)00364.
    

    >> Share

    
    April 2022
80. AHMED A, Shahid I, Siddiqi AK, Ellahi A, et al
    Meta-Analysis of Novel Glucose-Lowering Agents in Patients With Type 2 Diabetes Mellitus Without Pre-existing Heart Failure.
    Am J Cardiol. 2022 Apr 30. pii: S0002-9149(22)00362.
    

    >> Share

    
    
81. TURKBEY EB, Backlund JC, Gai N, Nacif M, et al
    Left Ventricular Structure, Tissue Composition, and Aortic Distensibility in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications.
    Am J Cardiol. 2022 Apr 29. pii: S0002-9149(22)00342.
    

    >> Share

    
    
82. PATOULIAS D, Doumas M, Papadopoulos C
    Meta-Analysis Assessing the Effect of Tirzepatide on the Risk for Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus.
    Am J Cardiol. 2022 Apr 19. pii: S0002-9149(22)00347.
    

    >> Share

    
    
83. PATOULIAS D, Doumas M, Kassimis G, Fragakis N, et al
    Meta-Analysis Evaluating the Efficacy of Sodium-Glucose Co-Transporter-2 Inhibitors in Patients With Acute or Recently Decompensated Heart Failure.
    Am J Cardiol. 2022 Apr 5. pii: S0002-9149(22)00260.
    

    >> Share

    
    March 2022
84. LEVI N, Dadon Z, Steinmetz Y, Perel N, et al
    Prevalence, Predictors, and Outcomes of Patients With ST-Elevation Myocardial Infarction and Angiographically Significant Coronary Artery Disease of Non-Infarct-Related Artery.
    Am J Cardiol. 2022 Mar 31. pii: S0002-9149(22)00235.
    

    >> Share

    
    
85. KEZERLE L, Haim M, Akriv A, Senderey AB, et al
    Relation of Hemoglobin A1C Levels to Risk of Ischemic Stroke and Mortality in Patients With Diabetes Mellitus and Atrial Fibrillation.
    Am J Cardiol. 2022 Mar 28. pii: S0002-9149(22)00173.
    

    >> Share

    
    
86. MOHEBI R, Jackson L, McCarthy CP, Murtagh G, et al
    Relation of High-Sensitivity Cardiac Troponin I and Obstructive Coronary Artery Disease in Patients Without Acute Myocardial Infarction.
    Am J Cardiol. 2022 Mar 28. pii: S0002-9149(22)00237.
    

    >> Share

    
    
87. AL RIFAI M, Vaughan EM, Abushamat LA, Lee M, et al
    Correlates of Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes Mellitus (from the Department of Veterans Affairs).
    Am J Cardiol. 2022 Mar 16. pii: S0002-9149(22)00166.
    

    >> Share

    
    
88. CAVALLARI I, Patti G, Maddaloni E, Veneziano F, et al
    Association Between Platelet Reactivity and Long-Term Bleeding Complications After Percutaneous Coronary Intervention According to Diabetes Status.
    Am J Cardiol. 2022 Mar 8. pii: S0002-9149(22)00124.
    

    >> Share

    
    February 2022
89. HAMMERMAN A, Moore CM, Aboalhasan E, Azuri J, et al
    Usefulness of Empagliflozin Versus Oral Semaglutide for Prevention of Cardiovascular Mortality in Patients With Type 2 Diabetes Mellitus.
    Am J Cardiol. 2022 Feb 20. pii: S0002-9149(22)00093.
    

    >> Share

    
    
90. LYU B, Grams ME, Chang A, Inker LA, et al
    Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-Like Peptide-1 Receptor Agonists, and Dipeptidyl Peptidase-4 Inhibitors, and Risk of Hospitalization.
    Am J Cardiol. 2022;165:124-130.
    

    >> Share

    
    January 2022
91. XIE PX, Li YG, Alsheikh-Ali AA, AlMahmeed W, et al
    Symptom Status, Clinical Subtypes, and Prognosis in Patients With Atrial Fibrillation from the Middle East Region (from the Gulf-SAFE Registry).
    Am J Cardiol. 2022 Jan 18. pii: S0002-9149(21)01278.
    

    >> Share

    
    
92. PATOULIAS D, Papadopoulos C, Karagiannis A, Doumas M, et al
    Meta-Analysis Assessing the Impact of Previous Heart Failure and Chronic Kidney Disease on the Cardiovascular Efficacy of Glucagon-Like Peptide-1 Receptor Agonists.
    Am J Cardiol. 2022 Jan 16. pii: S0002-9149(21)01259.
    

    >> Share

    
    
93. KAWJI MM, Glancy DL
    What is the Etiology of the Tall Initial R Wave in V1-V2?
    Am J Cardiol. 2022;163:130-131.
    

    >> Share

    
    
94. BAILEY-DAVIS L, Wood GC, Benotti P, Cook A, et al
    Impact of Sustained Weight Loss on Cardiometabolic Outcomes.
    Am J Cardiol. 2022;162:66-72.
    

    >> Share

    
    December 2021
95. PATOULIAS D, Michailidis T, Papadopoulos C, Karagiannis A, et al
    Meta-Analysis of Randomized Controlled Trials Evaluating the Effect of Dual Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 Receptor Agonists on Blood Pressure Levels in Patients With Type 2 Diabetes Mellitus.
    Am J Cardiol. 2021 Dec 30. pii: S0002-9149(21)01162.
    

    >> Share

    
    
96. WAN SH, Slusser JP, Hodge DO, Chen HH, et al
    Outcomes of Patients With Diabetes Versus Patients Without Diabetes Hospitalized With Acute Heart Failure.
    Am J Cardiol. 2021 Dec 17. pii: S0002-9149(21)01105.
    

    >> Share

    
    
97. SKIPINA TM, Patel N, Upadhya B, Soliman EZ, et al
    Relation of Cannabis Use to Elevated Atherosclerotic Cardiovascular Disease Risk Score.
    Am J Cardiol. 2021 Dec 17. pii: S0002-9149(21)01103.
    

    >> Share

    
    
98. YOSHIOKA G, Natsuaki M, Goriki Y, Shinzato K, et al
    Serum Albumin and Bleeding Events After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction (from the HAGAKURE-ACS Registry).
    Am J Cardiol. 2021 Dec 7. pii: S0002-9149(21)01099.
    

    >> Share

    
    
99. JIAYASPATHI A, Chen LY, Selvin E, Gottesman RF, et al
    Relation of Diabetes Mellitus to Incident Dementia in Patients With Atrial Fibrillation (from the Atherosclerosis Risk in Communities Study).
    Am J Cardiol. 2021 Dec 6. pii: S0002-9149(21)01093.
    

    >> Share

    
    November 2021
100. PATOULIAS D, Papadopoulos C, Kassimis G, Vassilikos V, et al
     Meta-Analysis Addressing the Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Flow-Mediated Dilation in Patients With Type 2 Diabetes Mellitus.
     Am J Cardiol. 2021 Nov 29. pii: S0002-9149(21)01092.
     

     >> Share

     
     
101. YAMAMOTO K, Natsuaki M, Morimoto T, Shiomi H, et al
     Coronary Artery Disease Without Standard Cardiovascular Risk Factors.
     Am J Cardiol. 2021 Nov 28. pii: S0002-9149(21)01052.
     

     >> Share

     
     
102. GUPTA K, Viacava RC, Jain V, Kakar TS, et al
     Trends in Patient-Recalled Targets for Cardiovascular Risk Factors in Ambulatory US Adults With Diabetes Mellitus (from National Health and Nutrition Examination Survey).
     Am J Cardiol. 2021 Nov 25. pii: S0002-9149(21)01037.
     

     >> Share

     
     
103. COSTA R, Trepa M, Oliveira M, Frias A, et al
     Heart Failure Incidence Following ST-Elevation Myocardial Infarction.
     Am J Cardiol. 2021 Nov 21. pii: S0002-9149(21)01050.
     

     >> Share

     
     
104. AL-ABDOUH A, Mhanna M, Barbarawi M, Abusnina W, et al
     A Meta-Analysis of the Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Heart Failure and Preserved Ejection Fraction.
     Am J Cardiol. 2021 Nov 16. pii: S0002-9149(21)01036.
     

     >> Share

     
     October 2021
105. KIM TO, Ahn JM, Kang DY, Park H, et al
     Long-Term Outcomes After Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents or Coronary Artery Bypass Grafting for Multivessel Coronary Disease.
     Am J Cardiol. 2021 Oct 2. pii: S0002-9149(21)00825.
     

     >> Share

     
     September 2021
106. O'KEEFE EL, Sturgess JE, O'Keefe JH, Gupta S, et al
     Prevention and Treatment of Atrial Fibrillation via Risk Factor Modification.
     Am J Cardiol. 2021 Sep 25. pii: S0002-9149(21)00827.
     

     >> Share

     
     
107. PATOULIAS D, Papadopoulos C, Kassimis G, Karagiannis A, et al
     Updated Meta-Analysis of Cardiovascular Outcome Trials Evaluating Cardiovascular Efficacy of Glucagon-Like Peptide-1 Receptor Agonists.
     Am J Cardiol. 2021 Sep 5. pii: S0002-9149(21)00765.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share